Chronotherapeutic Drug Delivery Platform

Researchers at the University of Strathclyde have developed a novel platform oral delivery system that provides optimal controlled drug release profiles without the need for expensive and time consuming processes. This technology provides a simple cost-effective platform that can be used to deliver combinations of drugs to the body at optimal times to maximise therapeutic benefit.

Key Benefits

Oral drug delivery platform technology with the unique ability to deliver drug combinations in complex release patterns
The delivery device performs independently of gastrointestinal pH to allow time-specific release
Streamlined manufacturing process that is readily scaleable
This delivery device presents the opportunity to aid patient compliance and has the potential to minimise drug related side effects

Applications

This is a platform technology and so the market potential of this delivery system is broad – clinical areas for application of this technology include, but are not limited to, hypertension, asthma, anxiety, epilepsy, pain, sleep disorders and infections.

IP Status

The technology is a novel finding that constitutes a patentable invention. The IP is protected through non-disclosure and contact is welcomed from organisations interested in developing or exploiting this technology.

If you would like further information about this opportunity please fill out the form below. Your enquiry will be passed on to the relevant University who will respond to you directly.

OPPORTUNITY	Chronotherapeutic Drug Delivery Platform
NAME*
COMPANY NAME
COUNTRY
EMAIL*
TELEPHONE
	* denotes compulsory field

If you register you will receive automatic email notification of technologies in the sectors you indicate. Filling on the form takes only a few minutes and will ensure you are kept up to date with new additions to the university-technology website.